Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease - Wikidata - awgldk - TriplyDB

Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease

Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease

http://www.wikidata.org/entity/Q24187920

about

Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults Interventions to improve patient access to and utilisation of genetic and genomic counselling services Pregnancy in women with thalassemia: challenges and solutions Inclusion of diverse populations in genomic research and health services: Genomix workshop report.Methods to estimate access to care and the effect of interventions on the outcomes of congenital disorders

P2860

Q24185822-7E061DB6-8671-4E39-A072-0C9016AD6563 Q24188203-6F5BE1D3-E236-46A2-A20E-257279750883 Q28080216-7BEAED24-EB14-4E85-B9E2-D68B55664A11 Q42364502-BA6B6554-635D-4D78-A906-4C91749B3384 Q58045912-162CE4E9-F7DC-4600-B2C0-10E32EDA0A27

P2860

Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease

http://www.wikidata.org/entity/Q24187920

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@ast

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@en

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@en-gb

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@nl

type

label

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@ast

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@en

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@en-gb

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@nl

prefLabel

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@ast

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@en

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@en-gb

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@nl

P1433

Q24187920-A49B5BC5-ADE4-4DBA-9B10-E15AF3C9FE93

P1476

Q24187920-6FFC5837-5AE4-407A-8040-46C00D05AF04

P2093

Q24187920-29E897E2-ED3B-4829-A106-6E6113721A8F

P2860

Q24187920-0BBA71D9-C64D-4710-8BE3-A6F174B4E199

Q24187920-0F5B58BB-761A-4FCB-9A9C-9E6EF76BF091

Q24187920-10CC7642-883F-41D2-8ADB-14C8EA55F8D2

Q24187920-142F2A63-4148-4CF2-848A-8C8ECF2FDCDB

Q24187920-150ADC34-2D0A-43E1-9921-A358C383BCB7

Q24187920-1D4F6A35-C200-4FD6-B911-CCBA16447E41

Q24187920-235F7EC2-F726-40DA-9B99-364439621C2B

Q24187920-27482F13-55A6-48B8-AA1B-20477D2CE50E

Q24187920-2B7DA6D0-C220-4929-BE03-6DD4D7FD93A1

Q24187920-3516E826-F98A-463F-973D-0928F6E09306

P304

Q24187920-8DA20371-30FB-424F-9AED-C6C2DEDFEFCA

P31

Q24187920-C0FBC7D0-C954-4F3F-9B91-B4F6B4FB40B1

P3181

Q24187920-17156AA1-7725-4E4D-B168-14D05D187851

P356

Q24187920-948220B0-635B-4DF5-AF6A-47529FE7401E

P433

Q24187920-CE71AE32-4BF8-44AC-A65F-488FC8F78048

P50

Q24187920-0A469135-B737-46AA-843D-985DD36DC034

Q24187920-402A0919-833D-40A0-B1F8-B119026F8949

Q24187920-6E55806C-9CE5-473A-875E-E938D8FE58BF

Q24187920-D6F13A9E-6002-419A-88FF-6EA0AF94171D

P577

Q24187920-9B5D6415-0672-47A2-BD8B-773101496DA4

P698

Q24187920-D14DEA22-2035-4608-8AF4-CDDEA24EB797

P921

Q24187920-8A1CB4C6-34A2-4EEC-9F82-F8A6DECB9241

Q24187920-F49885F6-28F0-433B-A283-5C1C19E7F357

P932

Q24187920-816A6940-D52D-4471-B668-1D86218A8346

P3181

P356

14651858.CD010849.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Preconception risk assessment ...... fibrosis and Tay-Sachs disease

@en

P2093

Jos Kleijnen

http://www.w3.org/2001/XMLSchema#string

P2860

Psychological interventions for people with cystic fibrosis and their families

Iranian national thalassaemia screening programme

Quantifying heterogeneity in a meta-analysis

The estimation of intraclass correlation in the analysis of family data

ABC of clinical haematology. The hereditary anaemias

Do consanguineous parents of a child affected by an autosomal recessive disease have more DNA identical-by-descent than similarly-related parents with healthy offspring? Design of a case-control study.

The impact of population based screening for carriers of cystic fibrosis.

Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure.

Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model.

Reproductive options for individuals at risk for transmission of a genetic disorder.

P304

CD010849

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3612073

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD010849.PUB2

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26264938

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

sickle-cell disease

P932

6486309

http://www.w3.org/2001/XMLSchema#string